Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 Label

YMAB: Y-mAbs Therapeutics, Inc
2020-10-14 09:00:10
Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 Labeled Omburtamab Antibody
Beyond Technical Analysis

免責聲明